Clinical Trials Browser

Withdrawn × Carcinoma, Non-Small-Cell Lung × bavituximab × Clear all

NCT02673814 2016-08-01

Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung